| 2024/05/03 17:38:11 | |
|---|---|
| Price | |
| 38.36 EUR | |
| Difference | 3.73% (1.38) |
General attributes
| ISIN | DE0005659700 |
| Symbol | EUZ |
| Exchange | Xetra |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 799 EUR |
| Benchmark | GERMANY DAX |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 37.08 EUR |
| High | 38.86 EUR |
| Low | 37.08 EUR |
| Close (prev. day) | 36.98 EUR |
| VWAP | 38.33365 EUR |
| Volume (pcs) | 53,726 |
| Trading volume | 2,059,513.88 |
| Number of trades | 699 |
| Last size | 74 |
Futures and Options
| Related Futures | - |
| Related Options | 637 |
PDF Downloads
| Company report: ECKERT & ZIEGLER SE |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/04/26 |
|
Global Equity Ratings |
|
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/03/13 |
|
Global Equity Ratings |
|
| 2024/02/22 |
|
Global Equity Ratings |
|
| 2024/02/14 |
|
Global Equity Ratings |
|
| 2024/05/03 17:38:11 | |
|---|---|
| Price | |
| 38.36 EUR | |
| Difference | 3.73% (1.38) |
General attributes
| ISIN | DE0005659700 |
| Symbol | EUZ |
| Exchange | Xetra |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 799 EUR |
| Benchmark | GERMANY DAX |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 37.08 EUR |
| High | 38.86 EUR |
| Low | 37.08 EUR |
| Close (prev. day) | 36.98 EUR |
| VWAP | 38.33365 EUR |
| Volume (pcs) | 53,726 |
| Trading volume | 2,059,513.88 |
| Number of trades | 699 |
| Last size | 74 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | +1.70% | -18.24% | -53.36% |
| Perf (abs.) | +0.64 | -8.56 | -43.89 |
| Beta | 1.43 | 1.44 | 1.40 |
| Volatility | 40.35 | 39.50 | 48.74 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 37.47 EUR (31,061) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 36.46 EUR (52,740) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 39.92 EUR (54,842) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 37.62 EUR (55,309) |
| YTD High | date | 46.90 EUR (2024/01/31) |
| YTD Low | date | 32.74 EUR (2024/04/19) |
| 52 Weeks High | date | 50.05 EUR (2023/05/16) |
| 52 Weeks Low | date | 28.92 EUR (2023/09/13) |
All listings for ECKERT & ZIEGLER SE
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Xetra | 2024/05/03 | 17:38 | 38.36 EUR | 2.06 | 699 |
| Tradegate | 2024/05/03 | 22:26 | 38.60 EUR | 0.72 | 162 |
| Stuttgart | 2024/05/03 | 21:55 | 38.42 EUR | 0.15 | 73 |
| Munich | 2024/05/03 | 08:02 | 37.28 EUR | 0.00 | 1 |
| London Stock Exchange European Trade Reporting | 2024/05/03 | 17:30 | 38.44 EUR | 0.00 | 1 |
| Hanover | 2024/05/03 | 08:16 | 36.94 EUR | 0.00 | 3 |
| Hamburg | 2024/05/03 | 08:16 | 36.94 EUR | 0.00 | 1 |
| Frankfurt | 2024/05/03 | 11:11 | 37.86 EUR | 0.01 | 2 |
| Euronext Milan MTF Trading After Hours | 2024/05/03 | 17:44 | 38.42 EUR | 0.00 | 1 |
| Euronext Milan MTF Global Equity Market | 2024/05/03 | 17:44 | 38.42 EUR | 0.00 | 1 |
| Duesseldorf | 2024/05/03 | 19:31 | 38.26 EUR | 0.00 | 7 |
| Berlin | 2024/05/03 | 21:52 | 38.58 EUR | 0.00 | 17 |
Company Logo
Contact Details
| ECKERT & ZIEGLER SE |
| - - |
| Robert-Rössle-Strasse 10 - 13125 Berlin |
| Telefon: +49-30-94-10-84-0 |
| Fax: +49-30-94-10-84-112 |
| E-mail: info@ezag.de |
PDF Downloads
| Company report: ECKERT & ZIEGLER SE | |
Company Profile
Eckert & Ziegler SE is a holding company, which engages in the processing of radio isotopes. It also focuses on the development, production, and sale of isotope technology components and related products. It operates through the following segments: Isotope Products, Medical, and Other. The Isotope Products segment manufactures and distributes standards, and radiation sources for medical and industrial purposes. The Medical segment offers small radioactive implants for treating prostate cancer and eye applications for treating uveal melanoma. The Other segment focuses pools internal group services like radiation protection, legal, accounting, information technology, and human resources. The company was founded by Andreas Eckert in 1997 and is headquartered in Berlin, Germany. |
Members of Management Board
| Harald Hasselmann | Chairman of Managing Board |
| Franklin Yeager | Member of Executive Committee |
| Jutta Ludwig | Member of Executive Committee |
Board of directors
| Andreas Eckert | Chairman of Supervisory Board |
| Edgar Löffler | Member of Supervisory Board |
| Helmut Grothe | Member of Supervisory Board |
| Albert Rupprecht | Member of Supervisory Board |
| Frank Perschmann | Member of Supervisory Board |
| Paola Eckert-Palvarini | Member of Supervisory Board |